Entecavir Hydrate: A Potent Antiviral for Chronic Hepatitis B Treatment
Discover the efficacy and applications of Entecavir hydrate, a critical pharmaceutical raw material for combating Hepatitis B.
Get a Quote & SampleProduct Core Value
Entecavir Hydrate
Entecavir hydrate is a highly pure pharmaceutical raw material, essential for the treatment of chronic Hepatitis B. Its nucleoside analogue structure allows it to effectively inhibit the replication of the Hepatitis B virus (HBV) by targeting its polymerase. This compound meets stringent quality standards, including USP, BP, and EP, ensuring its suitability for pharmaceutical applications.
- Unlock the potential of Entecavir hydrate as a potent antiviral drug for patients suffering from chronic Hepatitis B, offering a significant therapeutic advantage.
- Leverage its high purity (≥ 99%), ensuring reliable and effective pharmaceutical formulations that adhere to global quality standards.
- Understand the mechanism of action: Entecavir hydrate acts as a nucleoside analogue, inhibiting HBV polymerase and its replication cycle.
- Benefit from its well-defined pharmacokinetic profile, enabling predictable drug absorption, distribution, metabolism, and clearance for optimal patient outcomes.
Key Advantages of Entecavir Hydrate
Potent Antiviral Efficacy
Entecavir hydrate demonstrates strong antiviral capacity, effectively reducing viral DNA levels in chronic Hepatitis B patients, contributing to improved liver health.
Low Drug Resistance Rate
Studies indicate a consistently low drug resistance rate with long-term application, making it a reliable option for sustained treatment of HBV.
Pharmaceutical Grade Quality
Meeting USP, BP, and EP standards, this Entecavir hydrate pharmaceutical raw material ensures quality and safety for drug manufacturing.
Key Applications
Antiviral Therapy
Used as a pharmaceutical raw material, Entecavir hydrate is a primary choice for the oral antiviral treatment of Hepatitis B virus infection.
Chronic Hepatitis B Management
Its potent inhibitory effect on HBV polymerase makes it crucial for managing chronic Hepatitis B, offering superior curative effects compared to some older treatments.
Drug Development
Serves as a critical active pharmaceutical ingredient (API) in the development of advanced pharmaceutical formulations targeting viral replication.
Research and Development
Essential for research into new antiviral strategies and understanding drug resistance mechanisms in viral infections.